|
|
Volumn 24, Issue 2, 2001, Pages 7-14
|
|
Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
AUSTRALIA;
COST BENEFIT ANALYSIS;
DECISION MAKING;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
EVALUATION;
HEALTH INSURANCE;
HUMAN;
LEGAL ASPECT;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
PUBLIC HEALTH;
REIMBURSEMENT;
STANDARD;
TREATMENT OUTCOME;
AUSTRALIA;
COST-BENEFIT ANALYSIS;
DECISION MAKING;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
INSURANCE, PHARMACEUTICAL SERVICES;
NATIONAL HEALTH PROGRAMS;
TREATMENT OUTCOME;
|
|
EID: 0035228140
PISSN: 01565788
EISSN: None
Source Type: Journal
DOI: 10.1071/AH010007 Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
